Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Drugs
861-880 of 1,312 results
-
-
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
-
Listen: ‘Death Certificate Project’ Aims At Opioid Crisis, But Doctors Cry Foul
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
-
Doctors Call California’s Probe Of Opioid Deaths A ‘Witch Hunt’
In a unique crackdown on what it sees as “excessive prescribing,” the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses — whether or not the doctors prescribed the fatal medications.
By Cheryl Clark -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
-
Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
By Jay Hancock and Sydney Lupkin -
Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
-
Meth’s Resurgence Spotlights Lack Of Meds To Combat The Addiction
While headlines continue to focus on the nation’s opioid crisis, a growing toll of overdoses and deaths related to methamphetamine use suggests this drug is making an under-the-radar comeback.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Bills, Bills, Bills: Readers And Tweeters Offer Solace, Solutions And Scoldings
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Emergency Medical Responders Confront Racial Bias
In a recent study of patients treated by emergency medical responders in Oregon, black patients were 40 percent less likely to get pain medicine than their white peers. Why?
-
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
-
Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment
Critics say patients are often misled by ads that advocate high-priced drugs or genetic tests.
By Liz Szabo -
Will I Always Face The Threat Of A Peanut-Laden Kiss Of Death?
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Tainted Drugs
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
-
Medicaid Patients In Puerto Rico Don’t Get Coverage For Drugs To Cure Hepatitis C
The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.
-
Podcast: KHN’s ‘What The Health?’ Ask Us Anything!
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
-
How Sen. Orrin Hatch Changed America’s Health Care
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.